Rani Therapeutics Holdings Inc. (NASDAQ: RANI)
$4.01
+0.0200 ( +0.50% ) 189.8K
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.
Market Data
Open
$4.01
Previous close
$3.99
Volume
189.8K
Market cap
$103.90M
Day range
$3.89 - $4.19
52 week range
$1.82 - $8.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jul 12, 2024 |
8-k | 8K-related | 48 | Jun 24, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |
8-k | 8K-related | 11 | May 30, 2024 |
4 | Insider transactions | 1 | May 30, 2024 |